PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
63.89
-1.02 (-1.58%)
Nov 12, 2026, 11:44 AM EST - Market open
PTC Therapeutics Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,156 | 1,731 | 806.78 | 937.82 | 698.8 | 538.59 |
Revenue Growth | -35.05% | 114.51% | -13.97% | 34.20% | 29.75% | 41.45% |
Gross Profit Gross Profit Growth | 637.69 | 1,228 | 214.9 | 205.77 | 2.63 | -34.42 |
Operating Income Operating Income Growth | 248.55 | 856.51 | -146.75 | -349.4 | -439.93 | -374.94 |
Net Income Net Income Growth | -105.97 | 682.64 | -363.3 | -626.6 | -559.02 | -523.9 |
Earnings Per Share EPS Growth | -1.28 | 7.78 | -4.73 | -8.37 | -7.79 | -7.43 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Sephience Sephience Growth | 549.34 | 111.15 | - | - | - | - |
Translarna Translarna Growth | 188.71 | 235.3 | 321.07 | 332.75 | - | - |
Emflaza Emflaza Growth | 98.26 | 146.36 | 207.22 | 255.09 | - | - |
Upstaza/Kebilidi Upstaza/Kebilidi Growth | 55.65 | 56.63 | 16.91 | 18.84 | - | - |
All Other Products All Other Products Growth | 32.31 | 37.26 | 36.95 | 31.5 | - | - |
Collaboration and License Collaboration and License Growth | 50.89 | 998.36 | 0.3 | 100.03 | 50.05 | 55.05 |
Royalty Royalty Growth | 279.01 | 244.22 | 203.86 | 168.86 | 113.52 | 54.64 |
Translarna France Translarna France Growth | - | -98.63 | 18.81 | 23.07 | - | - |
Manufacturing Manufacturing Growth | - | - | 1.66 | 7.69 | - | - |
Revenue (Total) Revenue (Total) Growth | 1,156 | 1,731 | 806.78 | 937.82 | 698.8 | 538.59 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,128 | 1,945 | 1,153 | 882.81 | 410.71 | 773.38 |
Total Debt Total Debt Growth | 2,942 | 2,707 | 2,471 | 2,229 | 1,462 | 1,269 |
Net Cash (Debt) Net Cash Growth | -813.72 | -761.69 | -1,318 | -1,346 | -1,051 | -495.99 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -9.83 | -8.63 | -17.15 | -17.99 | -14.65 | -7.04 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 10.49 | 711.2 | -107.69 | -158.42 | -356.65 | -251.33 |
Capital Expenditures CapEx Growth | -8.42 | -8.86 | -6.5 | -28.44 | -32.02 | -28.21 |
Free Cash Flow Free Cash Flow Growth | 2.07 | 702.34 | -114.19 | -186.86 | -388.67 | -279.55 |
Free Cash Flow Growth | -99.71% | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 55.18% | 70.98% | 26.64% | 21.94% | 0.38% | -6.39% |
Operating Margin | 21.51% | 49.49% | -18.19% | -37.26% | -62.95% | -69.62% |
Pretax Margin | -7.36% | 40.25% | -45.01% | -74.23% | -84.07% | -96.24% |
Profit Margin | -9.17% | 39.44% | -45.03% | -66.81% | -80.00% | -97.27% |
FCF Margin | 0.18% | 40.58% | -14.15% | -19.92% | -55.62% | -51.90% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 8.93 | - | - | - | - |
P/FCF Ratio | 2623.54 | 8.68 | - | - | - | - |
PS Ratio | 4.69 | 3.52 | 4.32 | 2.22 | 3.99 | 5.23 |